Dayton Misfeldt, Director, 10% Owner at SUNESIS PHARMACEUTICALS INC (SNSS), sold 300,700 shares at $8.16 ($2.4M) on 2014-08-27, disclosed to the SEC on 2014-08-29.
Open-market sale of $2.4M SNSS by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.16 | 1,883 | $15K | 0.6% |
| 2 | $8.16 | 98,817 | $806K | 33.6% |
| 3 | $7.89 | 3,740 | $30K | 1.2% |
| 4 | $7.89 | 196,260 | $1.5M | 64.5% |
| Total | $7.98 avg | 300,700 | $2.4M | 100% |
| Filing → |
| SNSS | SELL | 2015-12-21 | $2.2M | — | Filing → |
| SNSS | SELL | 2014-08-12 | $4.9M | — | Filing → |
| SNSS | BUY | 2010-07-01 | $6.7M | — | Filing → |